Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,736 public trials 631 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

NCT04800315

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Local Institution - 119 Birmingham, Alabama, United States
  • Cahaba Dermatology Birmingham, Alabama, United States
  • Local Institution - 114 Birmingham, Alabama, United States
View all 157 locations
View Trial Details
Completed

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis

NCT04856891

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Duodenitis, +13 more
Locations
  • Allakos Investigational Site Birmingham, Alabama, United States
  • Allakos Investigational Site Gilbert, Arizona, United States
  • Allakos Investigational Site Chula Vista, California, United States
  • Allakos Investigational Site Lomita, California, United States
View all 39 locations
View Trial Details
Completed

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis

NCT04322708

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Allakos Investigational Site Birmingham, Alabama, United States
  • Allakos Investigational Site Huntsville, Alabama, United States
  • Allakos Investigational Site Gilbert, Arizona, United States
  • Allakos Investigational Site Phoenix, Arizona, United States
View all 78 locations
View Trial Details
Completed

A Study to Assess AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis)

NCT04322604

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Duodenitis, +13 more
Locations
  • Allakos Investigational Site Birmingham, Alabama, United States
  • Allakos Investigational Site Huntsville, Alabama, United States
  • Allakos Investigational Site Gilbert, Arizona, United States
  • Allakos Investigational Site Phoenix, Arizona, United States
View all 60 locations
View Trial Details
Completed

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

NCT04206605

Conditions
Angioedema, Cardiovascular Diseases, Hypersensitivity, +7 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Medical Research of Arizona Scottsdale, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • AIRE Medical of Los Angeles Santa Monica, California, United States
View all 45 locations
View Trial Details

Related conditions